Product Name: ATP13A2 Antibody
Species Reactivity: Human
Tested Applications: WB
Applications: For WB starting dilution is: 1:1000
User Note: Optimal dilutions for each application to be determined by the researcher.
Predicted Molecular Weight: 129 kDa
Immunogen: This ATP13A2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 1133-1161 amino acids from the C-terminal region of human ATP13A2.
Host Species: Rabbit
Purification: This antibody is purified through a protein A column, followed by peptide affinity purification.
Physical State: Liquid
CAS NO.: 81742-10-1
Product: 3,6-Dichlorotrimellitic anhydride
Buffer: Supplied in PBS with 0.09% (W/V) sodium azide.
Concentration: 0.5 mg/ml
Storage Conditions: Store at 4˚C for three months and -20˚C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
Clonality: Polyclonal
Conjugate: Unconjugated
Alternate Names: Probable cation-transporting ATPase 13A2, 363-, ATP13A2, PARK9
Accession NO.: Q9NQ11
Protein Ino: 14285364
Official Symbol: ATP13A2
Geneid: 23400
Background: This gene encodes a member of the P5 subfamily of ATPaseswhich transports inorganic cations as well as other substrates.Mutations in this gene are associated with Kufor-Rakeb syndrome(KRS), also referred to as Parkinson disease 9. Multiple transcriptvariants encoding different isoforms have been found for this gene.
PubMed ID:http://aac.asm.org/content/53/7/2785.abstract
